Huang Shih-Cheng, Gau Shuo-Yan, Huang Jing-Yang, Wu Wen-Jun, Wei James Cheng-Chung
Institute of Medicine, Chung Shan Medical University, Taichung City 40201, Taiwan.
School of Medicine, Chung Shan Medical University, Taichung City 40201, Taiwan.
J Clin Med. 2022 May 14;11(10):2776. doi: 10.3390/jcm11102776.
Non-T2 asthma and hypothyroidism share several inflammatory mechanisms in common. However, large-scale, real-world studies evaluating the association between asthma and hypothyroidism are lacking. The objective of this study was to evaluate the risk for asthma patients of developing hypothyroidism.
In the retrospective cohort study, people with asthma were recruited from the Longitudinal Health Insurance Database in Taiwan. After excluding ineligible patients with a previous history of hypothyroidism, 1:1 propensity matching was conducted to select a non-asthma control group. Based on the multivariate Cox regression model, the adjusted hazard ratio of asthma patients developing hypothyroidism was calculated.
In total, 95,321 asthma patients were selected as the asthma group and the same amount of people without asthma were selected as the control group. The incidence levels of new-onset hypothyroidism in asthma and non-asthma groups were 8.13 and 6.83 per 100,000 people per year, respectively. Compared with the non-asthma group, the adjusted hazard ratio of the asthma group developing hypothyroidism was 1.217 (95% confidence interval, 1.091-1.357).
We found having asthma to be associated with an increased risk of hypothyroidism. Clinicians should be concerned regarding the endocrinological and inflammatory interaction between the two diseases while caring for people with asthma.
非T2哮喘和甲状腺功能减退症有几种共同的炎症机制。然而,缺乏评估哮喘与甲状腺功能减退症之间关联的大规模、真实世界研究。本研究的目的是评估哮喘患者发生甲状腺功能减退症的风险。
在这项回顾性队列研究中,从台湾纵向健康保险数据库招募哮喘患者。在排除有甲状腺功能减退症既往史的不符合条件的患者后,进行1:1倾向匹配以选择非哮喘对照组。基于多变量Cox回归模型,计算哮喘患者发生甲状腺功能减退症的调整后风险比。
总共选择95321例哮喘患者作为哮喘组,并选择相同数量的无哮喘患者作为对照组。哮喘组和非哮喘组新发甲状腺功能减退症的发病率分别为每年每10万人8.13例和6.83例。与非哮喘组相比,哮喘组发生甲状腺功能减退症的调整后风险比为1.217(95%置信区间,1.091 - 1.357)。
我们发现患哮喘与甲状腺功能减退症风险增加有关。临床医生在照顾哮喘患者时应关注这两种疾病之间的内分泌和炎症相互作用。